Oncotarget | Continuous Treatment With Abemaciclib Leads to Sustained and Efficient Inhibition of Breast Cancer Cell Proliferation
July 6, 2022
PRESS RELEASE: On July 2, a new research paper was published in Oncotarget, entitled, “Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation." continue reading »